Worth reading
66In focus
Scored from 4 of 5 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
450000
sharesWording
Conditional
How definitive the wording is.Details of issuance or disposal
Progress report on the mandatory exercise of Series 6 stock acquisition rights with a fixed exercise price
Who receives how much
450,000 shares (900 stock acquisition rights, 500 shares per right)
4 directors of the Company400,000 shares (800 stock acquisition rights)
1 director of a subsidiary of the Company50,000 shares (100 stock acquisition rights)
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
¥308 per share (subscription amount)
Amount of funds to be raised
Scheduled payment amount: ¥138,600,000; estimated net proceeds: Not disclosed
Specific use of funds
Business-related fundsAmount Specific allocation of funds has not been determined
Existing Shares and Increase
+1.31%Rate of increase
34,454,800 shares34,904,800Shares
1.31％
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Initial exercise price: ¥308. Adjusted from ¥1,540 to ¥308 due to a stock split. Adjustment provision: Not disclosed
Exercise period
Start Date 31 March 2025 / End date 31 March 2035
Number of Stock Acquisition Rights
Total issued: 1,000 rights; remaining unexercised: 900 rights
Stock Split Ratio1-for-5 stock split, effective 1 January 2026
Categories and Number of Persons Covered
Category Directors of the Company / Number of Employees 5 people (4 remaining) / Number of allocated shares 450,000 shares (400,000 remaining), Category Directors of the company's subsidiaries / Number of Employees 1 / Number of allocated shares 50,000 shares
Payment date
By 31 March 2035
Most recent equity financing
Timing 14 March 2025 / Type Stock acquisition rights with a share price target commitment (paid stock options) / Amount Not disclosed
Impact on Business Performance
If formally exercised, total proceeds of approximately ¥138 million will be raised and are expected to be allocated to business-related funding. The specific allocation of the amount and other details have not been determined.
| Item | Details |
|---|---|
| Type of issuance or disposal | Progress report on the mandatory exercise of Series 6 stock acquisition rights with a fixed exercise price |
| Number of shares to be issued or disposed of | 450,000 shares (900 stock acquisition rights, 500 shares per right) |
| Issue price and disposal price | ¥308 per share (subscription amount) |
| Amount of funds to be raised | Scheduled payment amount: ¥138,600,000; estimated net proceeds: Not disclosed |
| Specific use of funds | Details Business-related funds / Amount Specific allocation of funds has not been determined / Scheduled timing of expenditures Not disclosed |
| Payment date | By 31 March 2035 |
| Intended allottee | Name 4 directors of the Company / Number of Shares 400,000 shares (800 stock acquisition rights), Name 1 director of a subsidiary of the Company / Number of Shares 50,000 shares (100 stock acquisition rights) |
| Dilution Rate | 1.31％ |
| Total number of issued shares | 34,454,800 shares → 34,904,800 shares（1.31％） |
| Exercise price | Initial exercise price: ¥308. Adjusted from ¥1,540 to ¥308 due to a stock split. Adjustment provision: Not disclosed |
| Exercise period | Start Date 31 March 2025 / End date 31 March 2035 |
| Number of Stock Acquisition Rights | Total issued: 1,000 rights; remaining unexercised: 900 rights |
| Categories and Number of Persons Covered | Category Directors of the Company / Number of Employees 5 people (4 remaining) / Number of allocated shares 450,000 shares (400,000 remaining), Category Directors of the company's subsidiaries / Number of Employees 1 / Number of allocated shares 50,000 shares |
| Stock Split Ratio | 1-for-5 stock split, effective 1 January 2026 |
| Most recent equity financing | Timing 14 March 2025 / Type Stock acquisition rights with a share price target commitment (paid stock options) / Amount Not disclosed |
| Impact on Business Performance | If formally exercised, total proceeds of approximately ¥138 million will be raised and are expected to be allocated to business-related funding. The specific allocation of the amount and other details have not been determined. |
Items this document does not state (13)
Total issue valueEstimated issuance expensesIntended allottee's holding policyBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentProcedures under the Corporate Code of ConductMajor shareholders after the offeringAmount capitalised
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The mandatory exercise condition was met because the closing price of ¥136 on 13 November 2026 brought the 21-trading-day average closing price below ¥154, which is 50% of the ¥308 exercise price. The proceeds are expected to be allocated to business-related funding, but the specific allocation has not been determined.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.